Deerfield Management Company, L.P. (Series C) Charles River Laboratories International, Inc. Transaction History
Deerfield Management Company, L.P. (Series C)
- $5.38 Billion
- Q3 2024
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 2,204 shares of CRL stock, worth $413,250. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,204Holding current value
$413,250% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
694Shares Held
52.3MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.14 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$954 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$701 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$399 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$364 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.54B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...